Print(PDF/130KB) Mar. 02, 2021 Corporate
Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in the positions assumed by Executive Officers and other key positions, effective April 1, 2021:
I. Organizational Realignment (effective April 1, 2021)
Sales & Marketing (Division)
1. Kita-Kanto-Koshinetsu Branch is created by integrating Kita-Kanto Branch and Koshinetsu Branch.
2. Saitama-Chiba Branch is created by integrating Chiba Branch and Saitama Branch.
II. Changes in the Positions Assumed by Executive Officers (effective April 1, 2021)
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Representative Director, Executive Vice President Chief Scientific Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant |
Member, Board of Directors, Senior Executive Officer Chief Scientific Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant; Drug Research Division Senior Executive Research Director, Drug Research Division |
Toru Kimura |
Senior Executive Officer Drug Research Division Senior Executive Research Director, Drug Research Division |
Executive Officer Executive Research Director, Drug Research Division Senior Director, Research Planning & Coordination |
Hideyuki Harada |
Executive Officer Deputy Executive Director, Sales & Marketing Division |
Executive Officer Deputy Executive Director, Sales & Marketing Division Senior Director, Sales & Marketing Management |
Takuya Taguchi |
Executive Officer Executive Director, Technology Research & Development Division |
Executive Director, Technology Research & Development Division | Kenji Ueno |
III. Changes in Personnel (effective April 1, 2021)
Corporate Departments
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Senior Director, International Business Management | Managing Director, Sumitomo Pharmaceuticals (Thailand) Co., Ltd. | Tatsuya Ito |
Senior Medical Officer, Ophthalmology | Officer, Ophthalmology, Regenerative & Cellular Medicine Office | Koichiro Manabe |
Chair and CEO, Sumitomo Dainippon Pharma America, Inc. | Director, Accounting Group, Finance & Accounting | Koji Ishida |
Drug Research (Division)
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Senior Director, Research Planning & Coordination | Fellow, Synapse Pathology-based Drug Discovery, Pharmacology Research Unit | Masakuni Horiguchi |
Senior Director, Pharmacology Research Unit | Director, Pharmacology Group Ⅱ, Pharmacology Research Unit | Mitsugu Yamanaka |
Technology Research & Development (Division)
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Senior Director, Formulation Research & Development Laboratories | Director, Formulation Research Group Ⅲ, Formulation Research & Development Laboratories | Makiko Yanagida |
Sales & Marketing (Division)
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Senior Director, Sales & Marketing Management | Senior Director, Chugoku Branch | Yasutoshi Araki |
Senior Director, Kita-Kanto-Koshinetsu Branch | Senior Director, Kita-Kanto Branch | Takafumi Shimizu |
Senior Director, Saitama-Chiba Branch | Senior Director, Saitama Branch | Yasunori Shiroyama |
Senior Director, Chugoku Branch | Senior Director, Koshinetsu Branch | Yasushi Kimura |
Manufacturing (Division)
Position as of April 1, 2021 | Current position | Name |
---|---|---|
Senior Director, Manufacturing Management | Senior Director, Formulation Research & Development Laboratories | Kimihiro Mizuno |
Senior Director, Manufacturing Technology | Deputy Senior Director, Manufacturing Department I, Suzuka Plant | Hideo Kurita |
Senior Director, Suzuka Plant | Senior Director, Manufacturing Technology | Mitsuhito Kondo |
Deputy Senior Director, Manufacturing Department I, Suzuka Plant | Deputy Senior Director, Manufacturing Department II, Suzuka Plant | Toru Fukushima |
Deputy Senior Director, Manufacturing Department II, Suzuka Plant | Director, Narcotics Manufacturing Section, Manufacturing Department II, Suzuka Plant | Keishi Shigeyama |
Inquiries from the Press